5 4 8 6 5

论文已发表


注册即可获取德孚的最新动态



IF 收录期刊










更多详情 >>



国际纳米医学期刊(International Journal of Nanomedicine
‘2020年杰出科学家奖’
在线专题讲座

美国东部时间 9 月 10 日 12:00 – 1:00
(September 10th, 12:00 – 1:00 USA EST)

点击注册参加



讲座 ID:940 1333 6342
登录密码:998635





会员计划

我们很高兴为机构提供一种切实的方法以支持开放获取并鼓励教师和研究人员通过开放获取模式尽可能广泛地传播他们的作品。

更多详情 >>



 

视频

慢性阻塞性肺疾病急性加重期的抑郁和/或焦虑的多因素分析

 

Authors Long J, Ouyang Y, Duan H, Xiang Z, Ma H, Ju M, Sun D

Received 13 January 2020

Accepted for publication 30 April 2020

Published 19 June 2020 Volume 2020:15 Pages 1449—1464

DOI https://doi.org/10.2147/COPD.S245842

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. Chunxue Bai

Objective: To reveal the risk factors, the symptom distribution characteristics, the clinical values of white blood cell counts (WBC counts), red blood cell distribution width (RDW), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and monocyte-to-lymphocyte ratio (MLR) in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) combined with depression and/or anxiety.
Methods: The study included prospective cross-sectional and case–control studies, and was executed in the Affiliated Hospital of Zunyi Medical University, Guizhou, China. Previously diagnosed chronic obstructive pulmonary disease (COPD) patients who admitted to the hospital with AECOPD, patients with depression and/or anxiety, and healthy people were enrolled in the study. The Hamilton Rating Scales were used to assess all subjects, and the complete blood counts (CBC) were collected. Baseline data and clinical measurement data [spirometry, arterial blood gas analysis, and COPD evaluation test (the CAT scale)] from patients with AECOPD were collected.
Results: Of the 307 patients with AECOPD included, 63.5% (N=195) had depressive and/or anxiety symptoms, and 36.5% (N=112) had no symptoms. Sex, respiratory failure, number of comorbidities, number of acute exacerbations in the previous year and the CAT score were closely related to AECOPD combined with depression and/or anxiety (p< 0.05). The CAT scale score were the independent risk factor (OR=6.576, 95% CI 3.812– 11.342) and significant predictor of AECOPD with depression and/or anxiety (AUC=0.790,95% CI 0.740– 0.834); the patients with depression and/or anxiety were more severe and characteristic than the patients with AECOPD combined with depression and/or anxiety; RDW was associated with AECOPD with depression and/or anxiety (p=0.020, OR1.212,95% CI1.03– 1.426), and had certain clinical diagnostic value (AUC=0.570,95% CI 0.531– 0.626).
Conclusion: Depression and anxiety should not be ignored in patients with AECOPD. The severity and quality of life of COPD were closely related to the occurrence of depression and/or anxiety symptoms. In most cases, perhaps depression and anxiety in AECOPD are only symptoms and not to the extents of the diseases. RDW had clinical diagnostic value in AECOPD combined with depression and/or anxiety. NLR, PLR, MLR, and RDW may become the novel indicators for evaluating the degree of inflammation of AECOPD and deserve further research.
Keywords: AECOPD, anxiety, depression, comorbidities, Hamilton Rating Scale, inflammatory markers, symptomatology